Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Carpenter

Showing results (21-30 of 33) with videos related to

Pageof 4
Sort By:
Human Movement Science|December 12, 2018
Postural control, falls and Parkinson's disease: Are fallers more asymmetric than non-fallers?Fabio Augusto Barbieri, Mark Carpenter, Victor Spiandor Beretta, et al.
Vaccine|January 27, 2004
Immunization of colorectal cancer patients with recombinant baculovirus-derived KSA (Ep-CAM) formulated with monophosphoryl lipid A in liposomal emulsion, with and without granulocyte-macrophage colony-stimulating factorJeffrey Neidhart, Karen O Allen, Daunte L Barlow, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|August 6, 2002
Adenovirus-mediated transfer of BAX driven by the vascular endothelial growth factor promoter induces apoptosis in lung cancer cellsSergey A Kaliberov, Donald J Buchsbaum, G Yancey Gillespie, et al.
Research in Social & Administrative Pharmacy : RSAP|June 11, 2013
Expert panel assessment of acute liver injury identification in observational dataRichard A Hansen, Michael D Gray, Brent I Fox, et al.
Cancer Biotherapy & Radiopharmaceuticals|November 25, 2003
A novel monoclonal antibody design for radioimmunotherapyAndres Forero, Ruby F Meredith, M B Khazaeli, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 25, 2003
Antitumor efficacy of TRA-8 anti-DR5 monoclonal antibody alone or in combination with chemotherapy and/or radiation therapy in a human breast cancer modelDonald J Buchsbaum, Tong Zhou, William E Grizzle, et al.
International Journal of Radiation Oncology, Biology, Physics|November 7, 2002
Treatment of pancreatic cancer xenografts with Erbitux (IMC-C225) anti-EGFR antibody, gemcitabine, and radiationDonald J Buchsbaum, James A Bonner, William E Grizzle, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 22, 2005
Intraperitoneal pretarget radioimmunotherapy with CC49 fusion proteinDonald J Buchsbaum, M B Khazaeli, Donald B Axworthy, et al.
Cancer Biotherapy & Radiopharmaceuticals|October 27, 2005
Intraperitoneal radioimmunotherapy with a humanized anti-TAG-72 (CC49) antibody with a deleted CH2 regionBuck E Rogers, Peter L Roberson, Sui Shen, et al.
Journal of Neuropathology and Experimental Neurology|April 22, 2004
Prognostic value of 1p, 19q, 9p, 10q, and EGFR-FISH analyses in recurrent oligodendrogliomasKenneth B Fallon, Cheryl A Palmer, Kevin A Roth, et al.
Pageof 4

Showing results (21-30 of 33) with videos related to

Sort By:
Pageof 4
Human Movement Science|December 12, 2018
Postural control, falls and Parkinson's disease: Are fallers more asymmetric than non-fallers?Fabio Augusto Barbieri, Mark Carpenter, Victor Spiandor Beretta, et al.
Vaccine|January 27, 2004
Immunization of colorectal cancer patients with recombinant baculovirus-derived KSA (Ep-CAM) formulated with monophosphoryl lipid A in liposomal emulsion, with and without granulocyte-macrophage colony-stimulating factorJeffrey Neidhart, Karen O Allen, Daunte L Barlow, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|August 6, 2002
Adenovirus-mediated transfer of BAX driven by the vascular endothelial growth factor promoter induces apoptosis in lung cancer cellsSergey A Kaliberov, Donald J Buchsbaum, G Yancey Gillespie, et al.
Research in Social & Administrative Pharmacy : RSAP|June 11, 2013
Expert panel assessment of acute liver injury identification in observational dataRichard A Hansen, Michael D Gray, Brent I Fox, et al.
Cancer Biotherapy & Radiopharmaceuticals|November 25, 2003
A novel monoclonal antibody design for radioimmunotherapyAndres Forero, Ruby F Meredith, M B Khazaeli, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 25, 2003
Antitumor efficacy of TRA-8 anti-DR5 monoclonal antibody alone or in combination with chemotherapy and/or radiation therapy in a human breast cancer modelDonald J Buchsbaum, Tong Zhou, William E Grizzle, et al.
International Journal of Radiation Oncology, Biology, Physics|November 7, 2002
Treatment of pancreatic cancer xenografts with Erbitux (IMC-C225) anti-EGFR antibody, gemcitabine, and radiationDonald J Buchsbaum, James A Bonner, William E Grizzle, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 22, 2005
Intraperitoneal pretarget radioimmunotherapy with CC49 fusion proteinDonald J Buchsbaum, M B Khazaeli, Donald B Axworthy, et al.
Cancer Biotherapy & Radiopharmaceuticals|October 27, 2005
Intraperitoneal radioimmunotherapy with a humanized anti-TAG-72 (CC49) antibody with a deleted CH2 regionBuck E Rogers, Peter L Roberson, Sui Shen, et al.
Journal of Neuropathology and Experimental Neurology|April 22, 2004
Prognostic value of 1p, 19q, 9p, 10q, and EGFR-FISH analyses in recurrent oligodendrogliomasKenneth B Fallon, Cheryl A Palmer, Kevin A Roth, et al.
Pageof 4